Skip to Content

Breast Cancer: The Need for Axillary Clearances Can Be Significantly Reduced

In this MEDtalk, Marie-Jeanne Vrancken Peeters discusses tailored axillary treatments in patients with breast cancer who are treated with primary surgery first. She emphasizes that due to the effectiveness of systemic treatment, especially for triple-negative and HER2-positive diseases, the need for axillary clearances can be significantly reduced.

Marie-Jeanne Vrancken Peeters

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top